Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey E Kropf

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
The Journal of Organic Chemistry|February 25, 2006
Studies on a total synthesis of the microbial immunosuppresive agent FR901483Jeffrey E Kropf, Ivona C Meigh, Magnus W P Bebbington, et al.
The Journal of Organic Chemistry|May 1, 2007
Approach to the homoerythrina alkaloids using a tandem N-alkylation/azomethine ylide cycloadditionWilliam H Pearson, Jeffrey E Kropf, Allison L Choy, et al.
Journal of Medicinal Chemistry|May 1, 2014
Discovery of GS-9973, a selective and orally efficacious inhibitor of spleen tyrosine kinaseKevin S Currie, Jeffrey E Kropf, Tony Lee, et al.
Bioorganic & Medicinal Chemistry Letters|November 3, 2009
Imidazo[1,2-a]pyrazine diaryl ureas: inhibitors of the receptor tyrosine kinase EphB4Scott A Mitchell, Mihaela Diana Danca, Peter A Blomgren, et al.
ACS Medicinal Chemistry Letters|April 16, 2020
Discovery of Lanraplenib (GS-9876): A Once-Daily Spleen Tyrosine Kinase Inhibitor for Autoimmune DiseasesPeter Blomgren, Jayaraman Chandrasekhar, Julie A Di Paolo, et al.
ACS Medicinal Chemistry Letters|March 19, 2020
Discovery of Potent and Selective MTH1 Inhibitors for Oncology: Enabling Rapid Target (In)ValidationJulie Farand, Jeffrey E Kropf, Peter Blomgren, et al.
Bioorganic & Medicinal Chemistry Letters|December 18, 2015
Discovery of highly potent and selective Bruton's tyrosine kinase inhibitors: Pyridazinone analogs with improved metabolic stabilityWendy B Young, James Barbosa, Peter Blomgren, et al.
Bioorganic & Medicinal Chemistry Letters|February 22, 2015
Potent and selective Bruton's tyrosine kinase inhibitors: discovery of GDC-0834Wendy B Young, James Barbosa, Peter Blomgren, et al.
ACS Medicinal Chemistry Letters|June 20, 2017
Discovery of Potent and Selective Tricyclic Inhibitors of Bruton's Tyrosine Kinase with Improved Druglike PropertiesXiaojing Wang, James Barbosa, Peter Blomgren, et al.
Nature Chemical Biology|November 30, 2010
Specific Btk inhibition suppresses B cell- and myeloid cell-mediated arthritisJulie A Di Paolo, Tao Huang, Mercedesz Balazs, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
The Journal of Organic Chemistry|February 25, 2006
Studies on a total synthesis of the microbial immunosuppresive agent FR901483Jeffrey E Kropf, Ivona C Meigh, Magnus W P Bebbington, et al.
The Journal of Organic Chemistry|May 1, 2007
Approach to the homoerythrina alkaloids using a tandem N-alkylation/azomethine ylide cycloadditionWilliam H Pearson, Jeffrey E Kropf, Allison L Choy, et al.
Journal of Medicinal Chemistry|May 1, 2014
Discovery of GS-9973, a selective and orally efficacious inhibitor of spleen tyrosine kinaseKevin S Currie, Jeffrey E Kropf, Tony Lee, et al.
Bioorganic & Medicinal Chemistry Letters|November 3, 2009
Imidazo[1,2-a]pyrazine diaryl ureas: inhibitors of the receptor tyrosine kinase EphB4Scott A Mitchell, Mihaela Diana Danca, Peter A Blomgren, et al.
ACS Medicinal Chemistry Letters|April 16, 2020
Discovery of Lanraplenib (GS-9876): A Once-Daily Spleen Tyrosine Kinase Inhibitor for Autoimmune DiseasesPeter Blomgren, Jayaraman Chandrasekhar, Julie A Di Paolo, et al.
ACS Medicinal Chemistry Letters|March 19, 2020
Discovery of Potent and Selective MTH1 Inhibitors for Oncology: Enabling Rapid Target (In)ValidationJulie Farand, Jeffrey E Kropf, Peter Blomgren, et al.
Bioorganic & Medicinal Chemistry Letters|December 18, 2015
Discovery of highly potent and selective Bruton's tyrosine kinase inhibitors: Pyridazinone analogs with improved metabolic stabilityWendy B Young, James Barbosa, Peter Blomgren, et al.
Bioorganic & Medicinal Chemistry Letters|February 22, 2015
Potent and selective Bruton's tyrosine kinase inhibitors: discovery of GDC-0834Wendy B Young, James Barbosa, Peter Blomgren, et al.
ACS Medicinal Chemistry Letters|June 20, 2017
Discovery of Potent and Selective Tricyclic Inhibitors of Bruton's Tyrosine Kinase with Improved Druglike PropertiesXiaojing Wang, James Barbosa, Peter Blomgren, et al.
Nature Chemical Biology|November 30, 2010
Specific Btk inhibition suppresses B cell- and myeloid cell-mediated arthritisJulie A Di Paolo, Tao Huang, Mercedesz Balazs, et al.
Pageof 1